Zidovudine
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Sold as RETROVIR (AZT)
- Drug class
- Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
- Availability
- See label
- Routes
- Intravenous, Oral
- Markets covered
- 2
- Products on record
- 13
Overview
Zidovudine is an active pharmaceutical ingredient in the Nucleoside and Nucleotide Reverse Transcriptase Inhibitors group (J05AF). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 9 | April 17, 2026 |
| CA Canada | Health Canada | 4 | March 22, 2025 |
GBUnited Kingdom· MHRA
9 products
Uses
2).
How to take
CACanada· Health Canada
4 products
Uses
2 Recommended Dose and Dosage Adjustment 06/2021 7 WARNINGS AND PRECAUTIONS, General 06/2021 7 WARNINGS AND PRECAUTIONS, Hepatic/Biliary/Pancreatic 06/2021 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed.
RECENT MAJOR LABEL CHANGES ............................................................................................ 2 TABLE OF CONTENTS ..............................................................................................................
2 PART I: HEALTH PROFESSIONAL INFORMATION ...................................................................... 4 1 INDICATIONS ...............................................................................................................
5 2 CONTRAINDICATIONS ................................................................................................. 5 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ............................................................ 5 4 DOSAGE AND ADMINISTRATION .................................................................................
Drug interactions
Known interactions involving Zidovudine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 394. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL551830001 · revised April 17, 2026
- [2]Health Canada (DPD) · 01902644 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.